Who Owns uniQure N.V. Stock?
NASDAQ: QUREHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 22.73 +0.62%
Ownership breakdown
- Held by institutions
- 97.77%
- Held by insiders
- 1.26%
- Institutional holders
- 335
- Institutions 97.8%
- Insiders 1.3%
- Public and other 1.0%
Who owns uniQure N.V. stock?
Institutional investors own about 97.8% of uniQure N.V.'s shares, spread across 335 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.26% of QURE.
The largest institutional holders are Avoro Capital Advisors LLC (9.70%), JPMORGAN CHASE & CO (7.02%) and RTW Investments LP (5.68%). Together, the top 10 institutions control 42.8% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their QURE positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of QURE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Avoro Capital Advisors LLC | 6.73M | 9.70% | +12.9% |
| JPMORGAN CHASE & CO | 4.87M | 7.02% | +71.5% |
| RTW Investments LP | 3.94M | 5.68% | +52.4% |
| State Street Corporation | 2.90M | 4.19% | +28.5% |
| Aberdeen Group plc | 2.85M | 4.11% | -46.3% |
| Blackrock Inc. | 1.88M | 2.71% | +8.3% |
| Orbimed Advisors LLC. | 1.81M | 2.61% | -15.4% |
| Jane Street Group, LLC | 1.61M | 2.32% | +153.2% |
| Jennison Associates LLC | 1.56M | 2.25% | +26.6% |
| Boxer Capital Management, LLC | 1.50M | 2.17% | +127.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of QURE
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.53M | 3.64% |
| abrdn Healthcare Investors | 1.24M | 1.79% |
| J.P. Morgan Mutual Fd. Investment TRT-JPMorgan Growth Advantage Fd. | 1.24M | 1.78% |
| JPMorgan Trust II-JPMorgan Mid Cap Growth Fund | 959.05K | 1.38% |
| abrdn World Healthcare Fund | 792.58K | 1.14% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 758.04K | 1.09% |
| abrdn Life Sciences Investors | 564.24K | 0.81% |
| abrdn Healthcare Opportunities Fund | 496.97K | 0.72% |
| JPMorgan Trust II-JPMorgan Small Cap Growth Fund | 490.51K | 0.71% |
| iShares Trust-iShares Biotechnology ETF | 482.20K | 0.70% |
Frequently asked questions
Who is the largest shareholder of uniQure N.V.?
Avoro Capital Advisors LLC is the largest institutional shareholder of QURE, owning 9.70% of shares outstanding (6.73M shares) as of its latest 13F filing.
What percentage of uniQure N.V. is owned by institutions?
Institutions own about 97.8% of QURE shares and 99.0% of the public float.
How much of uniQure N.V. do insiders own?
Insiders, such as officers and directors, own about 1.26% of QURE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.